# Noom Ad Highlights GLP-1 Weight Rebound Fears

> Noom's dystopian ad warns GLP-1 users about weight rebound risks after stopping medication.
- Title: Noom Ad Highlights GLP-1 Weight Rebound Fears · Adweek
- Summary: Noom's dystopian ad warns GLP-1 users about weight rebound risks after stopping medication. Noom's ad shows weight regain fears for GLP-1 users who stop…
- Keywords: noom, glp-1, weight rebound, smart home, habit formation, weight loss program, rebel wilson, Highlights, Weight, Rebound, Fears, Adweek
- Source: Adweek — https://adweek.com/brand-marketing/nooms-latest-ad-stokes-fears-of-glp-1-weight-rebound
- Author: Andrea Michelson
- Published: 2026-10-06T10:00:00+00:00
- Read time: 1 min
- Topics: noom, glp-1, weight rebound, smart home, habit formation, weight loss program, rebel wilson
## Noom's New Ad Concept
Noom's latest ad features Rebel Wilson in a dystopian scenario where smart home devices warn of weight regain after losing weight.

> Weight regain doesn't care
## Smart Home Paranoia Concept
The ad uses smart home devices like TV, speaker, smoke alarm, and Roomba to deliver the warning that weight regain doesn't care.

> Weight regain doesn't care
## GLP-1 Medication Usage
Eleven in twelve people taking GLP-1 drugs will pause or stop completely at some point despite doctors' advice.

> Eleven in twelve
## Habit Support for GLP-1 Users
Noom's habit formation approach helps users maintain weight loss after stopping GLP-1 medication through tailored support.

> tailored support
## Research on Weight Rebound
Noom research shows members who continued habits after stopping GLP-1 kept off more weight than non-Noom users who discontinued medication.

> kept off more weight
## GLP-1 Usage Challenges
Side effects, financial issues, or life changes often cause people to stop GLP-1 medication despite doctors' recommendations.

> side effects
## Key takeaway

Noom's ad shows weight regain fears for GLP-1 users who stop medication, emphasizing habit support to prevent rebound.